Michelino De Laurentiis

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Michelino De Laurentiis
Jan 13, 2025, 15:28 | Insight
CAR-T cell therapy for breast cancer: Current status and future perspective
A recent paper by Giuseppe Buono, Medical Doctor at IRCCS National Cancer Institute "Fondazione G.…
Jan 12, 2025, 20:06 | Blog
Giuseppe Buono: Current status and future perspective of CAR-T cell therapy for breast cancer
Giuseppe Buono, Clinical and Translational Research Unit in Breast Cancer, IRCCS F. Pascale, Naples, shared…
Dec 28, 2024, 15:46 | Drugs
Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…
Dec 27, 2024, 10:48 | Drugs
Raffaele Colombo: Dato-DXd approved in Japan for HR+, HER-negative unresectable or recurrent breast cancer
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: “Datopotamab deruxtecan (dato-DXd)…
Dec 26, 2024, 15:50 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…
Oct 31, 2024, 07:36 | Blog
Erika Hamilton: Novel endocrine agents are coming
Erika Hamilton, Medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…
Aug 6, 2024, 02:02 | Insight
Trastuzumab deruxtecan therapy in patients with HER2-positive metastatic breast cancer
Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
Jul 31, 2024, 03:15 | Blog
Erika Hamilton: Happy to get the word out about the VERITAC2 trial
Erika Hamilton posted on LinkedIn about a recent paper, titled "VERITAC-2: a Phase III study of…
Jul 21, 2024, 10:33 | Blog
Filippo Montemurro: RWE of drug-drug interactions on abemaciclib
Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X: "Clinical…
All: 9 Posts: 1 - 100
Special Coverage